Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-001298

CEO and CFO bought 2,900 shares at an average $13.58 ($39,391)

From the SEC's structured data for this filing

Trades in this filing

Patel Snehal · CEO and CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-06 Purchase : show line 1 in the form +1,100 $13.31 $14,641 5,548,202 D
2025-01-07 Purchase : show line 2 in the form +1,800 $13.75 $24,750 5,550,002 D
Open-market purchases · 2,900 sh · avg $13.58 · $39,391
Loading xslF345X05/ownership.xml…